Market Overview

UPDATE: Goldman Sachs Upgrades PAREXEL International to Neutral on Stabilization, Financial Visibility

Related PRXL
PAREXEL International Announces Acquisition Of ATLAS Medical Services, A Provider Of Clinical Research Services In Turkey
Benzinga's Top Upgrades

Goldman Sachs upgraded PAREXEL International (NASDAQ: PRXL) from Sell to Neutral and raised its price target from $28.00 to $36.00.

Goldman Sachs noted, "From 2008-2012 PRXL increased headcount by 45% to meet the demands of several new strategic partners (in particular PFE). While we acknowledge that there are likely more strategic deals to come, we believe PRXL is better positioned today to manage associated disruptions. As such, we upgrade PRXL to Neutral from Sell and raise our price target to $36 from $28 which is now based on 12-months (6-months previously) and group average multiples (vs. previous discounts) given improved financial visibility."

PAREXEL International closed at $32.74 on Friday.

Posted-In: Goldman SachsAnalyst Color Upgrades Intraday Update Analyst Ratings

 

Related Articles (PRXL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters